|
Age (years)
|
Mean (SD)
|
56.75 (19.4)
|
56.53 (19.6)
|
62.67 (13.3)
|
0.008
|
|
Age (years)
|
n (%)
| | | |
0.002
|
| |
≤ 50
|
805 (38.2)
|
790 (38.8)
|
15 (20.3)
| |
| |
50–65
|
464 (22.0)
|
439 (21.6)
|
25 (33.8)
| |
| |
> 65
|
839 (39.8)
|
805 (39.6)
|
34 (45.9)
| |
|
Gender
|
Female n (%)
|
1177 (55.8)
|
1151 (56.6)
|
26 (35.1)
|
< 0.001
|
|
BMI (kg/m2)
|
Mean (SD)
|
26.27 (5.0)
|
26.10 (4.9)
|
30.90 (5.5)
|
< 0.001
|
|
BMI (kg/m2)
|
n (%)
| | | |
< 0.001
|
| |
≤ 25
|
917 (44.4)
|
908 (45.6)
|
9 (12.5)
| |
| |
> 25 - ≤ 30
|
763 (36.9)
|
735 (36.9)
|
28 (38.9)
| |
| |
> 30 - ≤ 35
|
268 (13.0)
|
252 (12.6)
|
16 (22.2)
| |
| |
> 35
|
117 (5.7)
|
98 (4.9)
|
19 (26.4)
| |
|
Smoking
|
n (%)
|
973 (47.0)
|
936 (46.9)
|
37 (51.4)
|
0.53
|
|
Atrial fibrillation
|
n (%)
|
58 (2.8)
|
55 (2.8)
|
3 (4.2)
|
0.71
|
|
Chronic heart failure: n (%):
|
n (%)
|
134 (6.4)
|
125 (6.1)
|
9 (12.2)
|
0.07
|
|
Kidney failure
|
n (%)
|
83 (3.9)
|
73 (3.6)
|
10 (13.5)
|
< 0.001
|
|
Stroke
|
n (%)
|
68 (3.2)
|
55 (2.7)
|
13 (17.6)
|
< 0.001
|
|
Characteristics of index VTE
|
n (%)
| | | |
0.032
|
| |
Isolated PE
|
558 (26.5)
|
530 (26.1)
|
28 (37.8)
| |
| |
PE associated with DVT
|
610 (29.0)
|
587 (28.9)
|
23 (31.1)
| |
| |
Isolated DVT
|
934 (44.4)
|
911 (44.9)
|
23 (31.1)
| |
|
Characteristics of recurrent VTE
|
n (%)
| | | |
0.23
|
| |
Isolated PE
|
63 (25.0)
|
61 (25.1)
|
2 (22.2)
| |
| |
PE associated with proximal DVT
|
44 (17.5)
|
40 (16.5)
|
4 (44.4)
| |
| |
PE associated with distal DVT
|
20 (7.9)
|
19 (7.8)
|
1 (11.1)
| |
| |
Isolated proximal DVT
|
84 (33.3)
|
83 (34.2)
|
1 (11.1)
| |
| |
Isolated distal DVT
|
41 (16.3)
|
40 (16.5)
|
1 (11.1)
| |
|
Anticoagulant duration
|
n (%)
| | | |
0.37
|
| |
≤ 90 days
|
190 (9.0)
|
184 (9.1)
|
6 (8.1)
| |
| |
> 90 - ≤ 180 days
|
543 (25.8)
|
527 (25.9)
|
16 (21.6)
| |
| |
> 180 - ≤ 360 days
|
895 (42.5)
|
866 (42.6)
|
29 (39.2)
| |
| |
> 360 days
|
478 (22.7)
|
455 (22.4)
|
23 (31.1)
| |
|
Unprovoked VTE
|
n (%)
|
1199 (56.9)
|
1148 (56.4)
|
51 (68.9)
|
0.044
|
|
Provoked VTE
|
n (%)
|
910 (43.1)
|
887 (43.6)
|
23 (31.1)
| |
|
Aspirin
|
n (%)
|
215 (10.2)
|
203 (10.0)
|
12 (16.2)
|
0.12
|
|
Statin
|
n (%)
|
192 (9.1)
|
181 (8.9)
|
11 (14.9)
|
0.12
|
|
CPAP
|
n (%)
|
63 (69.2)
|
0 (0.0)
|
63 (85.1)
|
< 0.001
|
|
OSA history
|
n (%)
|
46 (2.2)
|
0 (0.0)
|
46 (2.2)
| |
|
OSA occurrence
|
n (%)
|
28 (1.3)
|
0 (0.0)
|
28 (1.3)
| |
|
PSG or HST n (%)
| | |
17 (0.8)
|
57 (77.0)
| |
| |
Mean (SD)
| | | | |
| |
Total number of apneas
|
88.50 (105.4)
|
15.64 (22.6)
|
114.00 (111.2)
|
0.002
|
| |
Number of apneas by hours
|
11.92 (14.4)
|
1.81 (2.9)
|
15.37 (15.2)
|
0.002
|
| |
Number of obstructive apneas
|
59.58 (80.8)
|
6.93 (11.1)
|
78.97 (86.7)
|
0.003
|
| |
Number of central apneas
|
6.40 (17.5)
|
1.93 (4.9)
|
8.05 (20.1)
|
0.27
|
| |
Number of mixed apneas
|
8.92 (19.8)
|
1.21 (2.2)
|
11.76 (22.6)
|
0.09
|
| |
Apnea hypopnea index by hour
|
31.82 (20.8)
|
8.15 (4.3)
|
38.88 (18.4)
|
< 0.001
|
|
Nocturnal Desaturation
| | |
17 (0.8)
|
57 (77.0)
| |
| |
Mean (SD)
| | | | |
| |
Percentage of time < 90%
|
29.73 (31.3)
|
21.41 (32.4)
|
32.51 (30.7)
|
0.24
|
| |
Percentage of time < 85%
|
11.26 (22.1)
|
8.71 (23.0)
|
12.08 (22.0)
|
0.63
|
| |
Percentage of time < 80%
|
3.35 (12.1)
|
0.08 (0.3)
|
4.42 (13.8)
|
0.27
|
